Professor Leslie Burnett is a Clinical Pathologist, specialising in Chemical Pathology, Genetic Pathology and Bioinformatics. [More...]

Professor Leslie Burnett is a Clinical Pathologist, specialising in Chemical Pathology, Genetic Pathology and Bioinformatics.

He has served in a number of distinguished senior National and International professional roles in pathology, including being Chairman of the National Pathology Accreditation Advisory Council (NPAAC) of Australia (by Ministerial appointment), President of the Australasian Association of Clinical Biochemists (AACB), President of the National Coalition of Public Pathology (NCOPP), Chairman of the Quality Assurance, Scientific and Education Committee of the Royal College of Pathologists of Australasia (RCPA), Director of Pacific Laboratory Medicine Services (PaLMS) and Director and Chief Executive of Pathology North, NSW Health.

Professor Burnett pioneered the development and introduction of a number of pathology, genetics and management initiatives, including Community Genetics Screening in Australia, Cost Benchmarking in Pathology and pre-analytical Quality Assurance in Pathology. Today, all these initiatives are mainstream pathology and healthcare programs. The American Association of Clinical Chemistry (AACC) has awarded him its Management Sciences Award in recognition of "achievements of an individual who has made outstanding contributions in management sciences to the clinical laboratory and healthcare industry".

Professor Burnett is Clinical Professor in Pathology at the University of Sydney Medical School and Honorary Associate in the School of Molecular Bioscience as well as Adjunct Professor in Science and Technology at the University of Technology, Sydney. His current research activity is in the field of Genomic Bioinformatics and Computational Biology. [Hide detail]